Chi L Mo

Title: The Innovations of Chi L Mo

Introduction

Chi L Mo is a notable inventor based in Greenford, GB. He has made significant contributions to the field of pharmaceuticals, particularly in the development of antiviral agents. With a total of 2 patents to his name, his work has had a meaningful impact on therapeutic applications.

Latest Patents

Chi L Mo's latest patents include a process for the preparation of a carbocyclic nucleoside analogue. This process describes the preparation of carbocyclic guanosine from aristeromycin through a multi-step procedure. The final step involves the hydrolysis of a specific compound, where R¹ represents a C₁-₆ alkyl group or an arylC₁-₄ alkyl group, and R², R³, and R⁴ can be a hydrogen atom or a hydroxyl protecting group. Carbocyclic guanosine serves as an intermediate in synthesizing carbocyclic analogues of nucleosides, which are particularly useful in therapy as antiviral agents. Another significant patent involves carbocyclic analogues of 7H-1,2,3-triazolo [4,5-d]pyrimidine furanosides. This invention provides a compound of a specific formula and describes processes for their preparation, as well as their use in treating viral diseases, especially those caused by the Herpetoviridae.

Career Highlights

Chi L Mo is associated with Glaxo Group Limited, where he has been instrumental in advancing pharmaceutical research. His innovative approaches have contributed to the development of new therapeutic agents, showcasing his expertise in the field.

Collaborations

Chi L Mo has collaborated with notable colleagues, including Richard Storer and John P Turnbull. These partnerships have further enhanced the scope and impact of his research.

Conclusion

Chi L Mo's contributions to the field of pharmaceuticals through his patents and collaborations highlight his role as an influential inventor. His work continues to pave the way for advancements in antiviral therapies.